Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The study seeks to evaluate a novel treatment approach for performing continuous real-time
glucose sensing and insulin delivery at the same subcutaneous tissue site.